<DOC>
	<DOC>NCT01121653</DOC>
	<brief_summary>Use lay language. The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.</brief_summary>
	<brief_title>Impact of Oral Magnesium on Neuropathic Pain</brief_title>
	<detailed_description>Protocol description Visit D0 - patient inclusion after informed signed consent - clinical exam - blood sampling (magnesium dosage) - questionnaires (neuropathic pain and quality of life) - daily self-evaluation on neuropathic pain scale (Week0 to Week5) D8 : first intake of study drug (magnesium or placebo) Visit Week5: - questionnaires (neuropathic pain and quality of life) - blood sampling (magnesium dosage) - clinical exam</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>neuropathic pain informed signed consent magnesium intake contraindication severe renal insufficiency quinidine intake concomitant treatment change 2weeks before inclusion evolutive pathology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Neuropathic pain, magnesium</keyword>
</DOC>